GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Qiagen NV (FRA:QIA) » Definitions » Cyclically Adjusted FCF per Share

Qiagen NV (FRA:QIA) Cyclically Adjusted FCF per Share : €1.19 (As of Mar. 2024)


View and export this data going back to 1997. Start your Free Trial

What is Qiagen NV Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Qiagen NV's adjusted free cash flow per share for the three months ended in Mar. 2024 was €0.385. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €1.19 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Qiagen NV's average Cyclically Adjusted FCF Growth Rate was 7.40% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 19.20% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 12.20% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 7.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Qiagen NV was 29.10% per year. The lowest was 2.80% per year. And the median was 17.30% per year.

As of today (2024-05-16), Qiagen NV's current stock price is €41.695. Qiagen NV's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was €1.19. Qiagen NV's Cyclically Adjusted Price-to-FCF of today is 35.04.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Qiagen NV was 80.62. The lowest was 29.55. And the median was 44.95.


Qiagen NV Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Qiagen NV's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qiagen NV Cyclically Adjusted FCF per Share Chart

Qiagen NV Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.67 0.61 0.82 1.14 1.15

Qiagen NV Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.10 1.14 1.19 1.15 1.19

Competitive Comparison of Qiagen NV's Cyclically Adjusted FCF per Share

For the Diagnostics & Research subindustry, Qiagen NV's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Qiagen NV's Cyclically Adjusted Price-to-FCF Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Qiagen NV's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Qiagen NV's Cyclically Adjusted Price-to-FCF falls into.



Qiagen NV Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Qiagen NV's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.385/128.5800*128.5800
=0.385

Current CPI (Mar. 2024) = 128.5800.

Qiagen NV Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 0.148 99.240 0.192
201409 0.241 99.960 0.310
201412 0.174 99.050 0.226
201503 0.158 99.750 0.204
201506 0.161 100.230 0.207
201509 0.285 100.500 0.365
201512 0.181 99.730 0.233
201603 0.107 100.310 0.137
201606 0.281 100.260 0.360
201609 0.281 100.570 0.359
201612 0.300 100.710 0.383
201703 0.147 101.440 0.186
201706 0.149 101.370 0.189
201709 0.170 102.030 0.214
201712 0.162 101.970 0.204
201803 0.051 102.470 0.064
201806 0.324 103.100 0.404
201809 0.173 103.950 0.214
201812 0.245 103.970 0.303
201903 -0.422 105.370 -0.515
201906 0.182 105.840 0.221
201909 0.241 106.700 0.290
201912 0.241 106.800 0.290
202003 -0.048 106.850 -0.058
202006 0.050 107.510 0.060
202009 -0.186 107.880 -0.222
202012 0.733 107.850 0.874
202103 0.275 108.870 0.325
202106 0.406 109.670 0.476
202109 0.394 110.790 0.457
202112 0.569 114.010 0.642
202203 0.687 119.460 0.739
202206 0.570 119.050 0.616
202209 0.837 126.890 0.848
202212 0.328 124.940 0.338
202303 0.136 124.720 0.140
202306 0.332 125.830 0.339
202309 0.350 127.160 0.354
202312 0.406 126.450 0.413
202403 0.385 128.580 0.385

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Qiagen NV  (FRA:QIA) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Qiagen NV's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=41.695/1.19
=35.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Qiagen NV was 80.62. The lowest was 29.55. And the median was 44.95.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Qiagen NV Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Qiagen NV's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Qiagen NV (FRA:QIA) Business Description

Address
Hulsterweg 82, Venlo, LI, NLD, 5912 PL
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (over 45% of 2022 sales), followed by EMEA (nearly 35%), and Asia-Pacific (nearly 20%).
Executives
Dr. Metin Colpan Supervisory Board

Qiagen NV (FRA:QIA) Headlines

No Headlines